BIOR (Biora Therapeutics) חוב לטווח קצר להון

This price chart shows that the debt load of Biora Therapeutics (BIOR) is 0.00. Biora Therapeutics (BIOR) is implementing eco-standards in the development of drug delivery systems, adhering to bioethics and waste disposal regulations. The absence of market sales makes profit dependent on future licensing deals, while the business relies on third-party contractors for formula synthesis and clinical testing.

This indicator compares liabilities with a maturity of up to one year against net assets to determine the dependence of operational stability on short-term borrowing, which is critical for Biora Therapeutics (BIOR) when financing high-precision developments in the field of targeted drug delivery to the gastrointestinal tract; therefore, any sharp fluctuations on the short-term debt-to-equity chart signal a change in credit risk or business liquidity.